David J. Blanchard

Array ( [id] => 7288633 [patent_doc_number] => 20040109855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Therapeutic antibodies with reduced side effect' [patent_app_type] => new [patent_app_number] => 10/615718 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4387 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109855.pdf [firstpage_image] =>[orig_patent_app_number] => 10615718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742809 [patent_doc_number] => 20060088534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'HUMAN ANTI-FACTOR IX/IXA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 10/614959 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24642 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088534.pdf [firstpage_image] =>[orig_patent_app_number] => 10614959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263908 [patent_doc_number] => 07569673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors' [patent_app_type] => utility [patent_app_number] => 10/519580 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18501 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569673.pdf [firstpage_image] =>[orig_patent_app_number] => 10519580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887607 [patent_doc_number] => 20060275287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Scroll compressor' [patent_app_type] => utility [patent_app_number] => 10/518751 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275287.pdf [firstpage_image] =>[orig_patent_app_number] => 10518751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405186 [patent_doc_number] => 20040105815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => new [patent_app_number] => 10/603000 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11098 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105815.pdf [firstpage_image] =>[orig_patent_app_number] => 10603000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677385 [patent_doc_number] => 20060182740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Buffered formulations for concentrating antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/518434 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9424 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182740.pdf [firstpage_image] =>[orig_patent_app_number] => 10518434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361863 [patent_doc_number] => 20040091485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Humanised antibodies to the epidermal growth factor receptor' [patent_app_type] => new [patent_app_number] => 10/258728 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9220 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091485.pdf [firstpage_image] =>[orig_patent_app_number] => 10258728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609777 [patent_doc_number] => 07994289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Humanized anti-CD3 antibodies' [patent_app_type] => utility [patent_app_number] => 10/463442 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7702 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994289.pdf [firstpage_image] =>[orig_patent_app_number] => 10463442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449259 [patent_doc_number] => 20040067532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'High throughput generation and affinity maturation of humanized antibody' [patent_app_type] => new [patent_app_number] => 10/460595 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22278 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067532.pdf [firstpage_image] =>[orig_patent_app_number] => 10460595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270646 [patent_doc_number] => 07563882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Polynucleotides encoding antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 10/457829 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 136594 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563882.pdf [firstpage_image] =>[orig_patent_app_number] => 10457829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704723 [patent_doc_number] => 20060193771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins' [patent_app_type] => utility [patent_app_number] => 10/516766 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32585 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193771.pdf [firstpage_image] =>[orig_patent_app_number] => 10516766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468055 [patent_doc_number] => 20040120958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Modified antibodies to prostate-specific membrane antigen and uses thereof' [patent_app_type] => new [patent_app_number] => 10/449379 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 84159 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120958.pdf [firstpage_image] =>[orig_patent_app_number] => 10449379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395463 [patent_doc_number] => 20040018194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Recombinant anti-CD30 antibodies and uses thereof' [patent_app_type] => new [patent_app_number] => 10/447257 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 41488 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018194.pdf [firstpage_image] =>[orig_patent_app_number] => 10447257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 810357 [patent_doc_number] => 07417113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'PSCA: prostate stem cell antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/446542 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 90 [patent_no_of_words] => 45629 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/417/07417113.pdf [firstpage_image] =>[orig_patent_app_number] => 10446542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448944 [patent_doc_number] => 20040009944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Methylated immunostimulatory oligonucleotides and methods of using the same' [patent_app_type] => new [patent_app_number] => 10/437275 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26391 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009944.pdf [firstpage_image] =>[orig_patent_app_number] => 10437275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355854 [patent_doc_number] => 20040013649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Cancer vaccines and methods of using the same' [patent_app_type] => new [patent_app_number] => 10/437258 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 28015 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013649.pdf [firstpage_image] =>[orig_patent_app_number] => 10437258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364850 [patent_doc_number] => 20040005647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Anti-MUC-1 single chain antibodies for tumor targeting' [patent_app_type] => new [patent_app_number] => 10/435614 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23593 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005647.pdf [firstpage_image] =>[orig_patent_app_number] => 10435614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7371691 [patent_doc_number] => 20040219098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods for the treatment of tumors' [patent_app_type] => new [patent_app_number] => 10/429497 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8177 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219098.pdf [firstpage_image] =>[orig_patent_app_number] => 10429497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7371699 [patent_doc_number] => 20040219099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Method for the treatment of tumors' [patent_app_type] => new [patent_app_number] => 10/429515 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7157 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219099.pdf [firstpage_image] =>[orig_patent_app_number] => 10429515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7294998 [patent_doc_number] => 20040213792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Method for inhibiting cellular activation by insulin-like growth factor-1' [patent_app_type] => new [patent_app_number] => 10/422588 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12872 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213792.pdf [firstpage_image] =>[orig_patent_app_number] => 10422588 [rel_patent_id] =>[rel_patent_doc_number] =>)